Cargando…

Interference with pancreatic sympathetic signaling halts the onset of diabetes in mice

The notably lobular distribution of immune lesions in type 1 diabetes (T1D) has been hypothesized to be the result of innervation within the pancreas. To investigate whether neuroimmune interactions could explain this phenomenon, we explored the impact of sympathetic signaling in the RIP-LCMV-GP mou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christoffersson, Gustaf, Ratliff, Sowbarnika S., von Herrath, Matthias G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531904/ https://www.ncbi.nlm.nih.gov/pubmed/33052874 http://dx.doi.org/10.1126/sciadv.abb2878

Ejemplares similares

A Deeper Look into Type 1 Diabetes – Imaging Immune Responses during Onset of Disease
por: Christoffersson, Gustaf, et al.
Publicado: (2016)

Recent advances in understanding Type 1 Diabetes
por: Christoffersson, Gustaf, et al.
Publicado: (2016)

Means, Motive, and Opportunity: Do Non-Islet-Reactive Infiltrating T Cells Contribute to Autoimmunity in Type 1 Diabetes?
por: Rodriguez-Calvo, Teresa, et al.
Publicado: (2021)

Anti-IL17A Halts the Onset of Diabetic Retinopathy in Type I and II Diabetic Mice
por: Zhou, Amy Y., et al.
Publicado: (2023)

Combination Therapy With an Anti–IL-1β Antibody and GAD65 DNA Vaccine Can Reverse Recent-Onset Diabetes in the RIP-GP Mouse Model
por: Pagni, Philippe P., et al.
Publicado: (2014)

Response to Comment on Rodriguez-Calvo et al. Increase in Pancreatic Proinsulin and Preservation of β-Cell Mass in Autoantibody-Positive Donors Prior to Type 1 Diabetes Onset. Diabetes 2017;66:1334–1345
por: Rodriguez-Calvo, Teresa, et al.
Publicado: (2017)

Inhibition of CD40-TRAF6-dependent inflammatory activity halts the onset of diabetic retinopathy in streptozotocin-diabetic mice
por: Howell, Scott J., et al.
Publicado: (2022)

Three-dimensional Co-culture Model for Live Imaging of Pancreatic Islets, Immune Cells, and Neurons in Agarose Gel
por: Muntjewerff, Elke M., et al.
Publicado: (2023)

Direct Infection of Dendritic Cells during Chronic Viral Infection Suppresses Antiviral T Cell Proliferation and Induces IL-10 Expression in CD4 T Cells
por: Baca Jones, Carmen, et al.
Publicado: (2014)

Increase in Pancreatic Proinsulin and Preservation of β-Cell Mass in Autoantibody-Positive Donors Prior to Type 1 Diabetes Onset
por: Rodriguez-Calvo, Teresa, et al.
Publicado: (2017)

Putting a Halt to HALT: Does Anticoagulation Matter?
por: DeAnda, Abe, et al.
Publicado: (2022)

BDC12-4.1 T-Cell Receptor Transgenic Insulin-Specific CD4 T Cells Are Resistant to In Vitro Differentiation into Functional Foxp3(+) T Regulatory Cells
por: Sarikonda, Ghanashyam, et al.
Publicado: (2014)

Temporal Intra-Individual Variation of Immunological Biomarkers in Type 1 Diabetes Patients: Implications for Future Use in Cross-Sectional Assessment
por: Sarikonda, Ghanashyam, et al.
Publicado: (2013)

The neutrophil: one cell on many missions or many cells with different agendas?
por: Christoffersson, Gustaf, et al.
Publicado: (2018)

Aging related erectile dysfunction—potential mechanism to halt or delay its onset
por: Ferrini, Monica G., et al.
Publicado: (2017)

Can We Learn From Viruses How to Prevent Type 1 Diabetes?: The Role of Viral Infections in the Pathogenesis of Type 1 Diabetes and the Development of Novel Combination Therapies
por: von Herrath, Matthias
Publicado: (2009)

The Type 1 Diabetes Signature: Hardwired to Trigger Inflammation?
por: Coppieters, Ken T., et al.
Publicado: (2014)

Halting coronavirus polymerase
por: Kirchdoerfer, Robert N.
Publicado: (2020)

Halting the Allergic March
por: Van Bever, Hugo P, et al.
Publicado: (2008)

Halting 'research waste'
por: Shamsoddin, E., et al.
Publicado: (2021)

A Halt Called
Publicado: (1897)

Novel strategies halt cardiovascular, diabetes, and cancer strips
por: Hu, Chun-Song, et al.
Publicado: (2017)

The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes
por: Coppieters, Ken, et al.
Publicado: (2018)

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
por: Peakman, Mark, et al.
Publicado: (2010)

Viral Trigger for Type 1 Diabetes: Pros and Cons
por: Filippi, Christophe M., et al.
Publicado: (2008)

Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
por: de Groot, Pieter, et al.
Publicado: (2021)

Potential viral pathogenic mechanism in human type 1 diabetes
por: Schneider, Darius A., et al.
Publicado: (2014)

Bioengineering with Endothelial Progenitor Cells Improves the Vascular Engraftment of Transplanted Human Islets
por: Grapensparr, Liza, et al.
Publicado: (2018)

Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Optimizing the path from bench to bedside
por: Bresson, Damien, et al.
Publicado: (2009)

Functional Redundancy of CXCR3/CXCL10 Signaling in the Recruitment of Diabetogenic Cytotoxic T Lymphocytes to Pancreatic Islets in a Virally Induced Autoimmune Diabetes Model
por: Coppieters, Ken T., et al.
Publicado: (2013)

Coronavirus hält Weltkonjunktur in Atem
por: Gern, Klaus-Jürgen, et al.
Publicado: (2020)

Geminin halts DNA synthesis
por: LeBrasseur, Nicole
Publicado: (2004)

A Halt in Life's March
Publicado: (1887)

How Long Halt Ye?
Publicado: (1920)

How Long Halt Ye?
por: Glenton-Kerr, T.
Publicado: (1920)

How Long Halt Ye?
por: Kerr, T. Glenton
Publicado: (1921)

How Long Halt Ye?
Publicado: (1920)

How Long Halt Ye?
por: Coles, Richard J.
Publicado: (1921)

How Long Halt Ye?
por: Coles, Richard J.
Publicado: (1921)

How Long Halt Ye?
por: Coles, Richard J.
Publicado: (1920)

Cannot write session to /tmp/vufind_sessions/sess_oilchimpkbkc5rbpp6rh3cspmt